Skip to main content
James O'Bryan, MD, Internal Medicine, Washington, DC, MedStar Georgetown University Hospital

JamesBertrandO'BryanMD

Internal Medicine Washington, DC

Resident Physician at Georgetown University Hospital

Dr. O'Bryan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. O'Bryan's full profile

Already have an account?

Education & Training

  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2021 - 2024
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2021
  • University of North Carolina at Chapel Hill
    University of North Carolina at Chapel HillBS, Chemistry, 2012 - 2015

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2021 - 2024
  • VA State Medical License
    VA State Medical License 2021 - 2024

Publications & Presentations

Journal Articles

  • Gender Disparities in Outcomes of Cardiac Procedures with Amyloidosis using the National Inpatient Sample 2016-2019  
    Iyer, A., Dewaswala, N., Harris, C., Bhopalwala, H., Munshi, R.F., Towheed, A., Gupta, S., Minhas, A., Gaurang, V.N., Mishra, V., & O’Bryan, J., Journal of the Society for Cardiovascular Angiography and Interventions, 5/2022
  • Characteristics of Patients Presenting to Emergency Department for Primary Atrial Fibrillation or Flutter at an Academic Medical Center  
    Sadaf, M.I., O’Bryan, J., Biese, K., Chen, S., Deyo, Z., Mendys, P., Sears, S.F., Tuttle, H., Walker, T.J., & Gehi, A.K., Indian Heart Journal, 8/2021
  • Risk Stratified Tandem Versus Single Autologous Stem Cell Transplantation for Multiple Myeloma Yields Equivalent Survival  
    Sing, K., Sabo, R., O’Bryan, J., Risendal, M., Roberts, C., & Toor, A., American Society of Hematology, 11/5/2020
  • Join now to see all

Abstracts/Posters

  • Phase II clinical trial of olaparib plus pembrolizumab in the treatment of patients with advanced biliary tract cancer
    O’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., Journal of Clinical Oncology, 6/2023
  • Phase II Clinical Trial of Olaparib plus Pembrolizumab in the Treatment of Patients with Advanced Biliary Tract Cancer
    O’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., American Society of Clinical Oncology's Annual Meeting, Chicago, IL, 6/2023
  • Phase II Clinical Trial of Olaparib plus Pembrolizumab in the Treatment of Patients with Advanced Biliary Tract Cancer
    O’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., MedStar Health-Georgetown University Research & Education Symposium, Bethesda, MD, 5/2023
  • Join now to see all

Professional Memberships

Hospital Affiliations